StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.02−0.08 (-1.13%)

Close on Nov 17, 2026Market cap $254.77MP/E –Yield –

Evommune total assets

Total assets on the balance sheet at the end of each period.

Evommune's total assets was $278.30M at Sep 30, 2026. For fiscal 2025 it was $224.95M, up 195.8% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$224.95M+195.8%
FY2024Dec 31, 2024$76.06M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$278.30M+229.2%
Q2 FY2026Jun 30, 2026$301.95M+297.0%
Q1 FY2026Mar 31, 2026$322.46M–
Q4 FY2025Dec 31, 2025$224.95M–
Q3 FY2025Sep 30, 2025$84.54M–
Q4 FY2024Dec 31, 2024$76.06M–

More Evommune figures

See a number that looks wrong?